A South Florida company is voluntarily recalling weight loss supplements called "JaDera" and "Xiyouji Qingzhi."
Florida Dolphin Intertrade Corp. announced Friday that these products have been found to contain undeclared Sibutramine, which was a previously approved controlled substance for the treatment of obesity. It was removed from the U.S. market in October 2010 for safety reasons.
Florida Dolphin Intertrade says that products containing Sibutramine are known to substantially increase blood pressure and pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. These products may also interact in life threatening ways with other medications a consumer may be taking.
The supplements were distributed from May 2011 to May 2013.
Consumers with questions regarding this recall can contact 305-383-7600
Explore further: US warns of cancer-agent in Japan weight loss pills